Canadian Journal of Gastroenterology (Jan 1999)

Making Sense of Antisense

  • Bruce R Yacyshyn,
  • William R Shanahan

DOI
https://doi.org/10.1155/1999/154140
Journal volume & issue
Vol. 13, no. 9
pp. 745 – 751

Abstract

Read online

Since the identification of the DNA double-stranded helix, the gene as a target of therapy and, moreover, the use of DNA as a drug have been possibilities. ‘Antisense’ is used by some living organisms, specifically viruses, to control gene replication. Only recently, the use of antisense DNA as a mechanism to control human gene translation has been appreciated. A recent report on the use of systemically administered oligonucleotides in human Crohn’s disease is reviewed. DNA antisense oligonucleotides offer a technology capable of unique use at the laboratory bench as well as for highly specific therapeutic drugs. The conceptualization and possible future directions of these exciting compounds are reviewed.